Prolonged inhibition and incomplete recovery of mitochondrial function in oxazolidinone-treated megakaryoblastic cell lines
- 1 November 2019
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 54 (5) , 661-667
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Clinical safety and tolerability of tedizolid phosphate in the treatment of acute bacterial skin and skin structure infectionsExpert Opinion on Drug Safety, 2018
- Mitochondrial Alterations (Inhibition of Mitochondrial Protein Expression, Oxidative Metabolism, and Ultrastructure) Induced by Linezolid and Tedizolid at Clinically Relevant Concentrations in Cultured Human HL-60 Promyelocytes and THP-1 MonocytesAntimicrobial Agents and Chemotherapy, 2018
- Thrombocytopenia with Tedizolid and LinezolidAntimicrobial Agents and Chemotherapy, 2018
- A retrospective study of the risk factors for linezolid-induced thrombocytopenia and anemiaJournal of Infection and Chemotherapy, 2016
- In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and PneumoniaAntimicrobial Agents and Chemotherapy, 2015
- Risk factors for linezolid-associated thrombocytopenia in adult patientsInfection, 2014
- High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopeniaJournal of Antimicrobial Chemotherapy, 2013
- The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioningProceedings of the National Academy of Sciences, 2008
- The Site of Action of Oxazolidinone Antibiotics in Living Bacteria and in Human MitochondriaMolecular Cell, 2007
- Oxazolidinones Inhibit Cellular Proliferation via Inhibition of Mitochondrial Protein SynthesisAntimicrobial Agents and Chemotherapy, 2005